Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?

por Ndjeka, Norbert, Conradie, Francesca, Meintjes, Graeme, Reuter, Anja, Hughes, Jennifer, Padanilam, Xavier, Ismail, Nazir, Kock, Yulene, Master, Iqbal, Romero, Rodolfo, te Riele, Julian, Enwerem, Martin, Ferreira, Hannetjie, Maartens, Gary
Publicado 2020

Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa:...

por Ndjeka, Norbert, Campbell, Jonathon R, Meintjes, Graeme, Maartens, Gary, Schaaf, H Simon, Hughes, Jennifer, Padanilam, Xavier, Reuter, Anja, Romero, Rodolfo, Ismail, Farzana, Enwerem, Martin, Ferreira, Hannetjie, Conradie, Francesca, Naidoo, Kogieleum, Menzies, Dick
Publicado 2022

Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges

por Tadolini, Marina, Garcia-Prats, Anthony J., D'Ambrosio, Lia, Hewison, Catherine, Centis, Rosella, Schaaf, H. Simon, Marais, Ben J., Ferreira, Hannetjie, Caminero, Jose A., Jonckheere, Sylvie, Sinha, Animesh, Herboczek, Krzysztof, Khaidarkhanova, Zarema, Hayrapetyan, Armen, Khachatryan, Naira, Urtkmelidze, Ia, Loreti, Carolina, Esposito, Susanna, Matteelli, Alberto, Furin, Jennifer, Varaine, Francis, Migliori, Giovanni Battista
Publicado 2016